Incidence of subclinical atherosclerosis in asymptomatic type-2 diabetic patients: The potential of multi-slice computed tomography coronary angiography

Coronary Artery Disease

Volumn 22, Issue 1, 2011, Pages 26-31

  Silva, Joana D ^a   Mota, Paula ^a   Coelho, Álvaro ^a   Catarino, Rui ^a   Leitão Marques, António ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

asymptomatic; atherosclerosis; coronary artery disease; coronary computed tomography; primary prevention; screening; type 2 diabetes

Indexed keywords

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; FEMALE; FOLLOW UP; HUMAN; IMAGE QUALITY; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

AGED; ASYMPTOMATIC DISEASES; CALCINOSIS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY STENOSIS; CORONARY VESSELS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; IMAGE ENHANCEMENT; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78650774452     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e328340233b     Document Type: Article

References (30)

1. Pundziute G, Schuijf JD, Jukema JW, Boersma E, Scholte AJ, Kroft LJ, et al. Noninvasive assessment of plaque characteristics with multislice computed tomography coronary angiography in symptomatic diabetic patients. Diabetes Care 2007; 30:1113-1119.
2. International Diabetes Federation, available from http://www.idf.org.
3. Djaberi R, Schuijf JD, Boersma E, Kroft LJ, Pereira AM, Romijn JA, et al. Differences in atherosclerotic plaque burden and morphology between type 1 and 2 diabetes as assessed by multislice computed tomography. Diabetes Care 2009; 32:1507-1512.
4. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. Eur Heart J 2007; 28:88-136.
5. Iwasaki K, Matsumoto T, Aono H, Furukawa H, Samukawa M. Prevalence of subclinical atherosclerosis in asymptomatic diabetic patients by 64-slice computed tomography. Coron Artery Dis 2008; 19:195-201.
6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the NCEP (Adult Treatment Panel III). JAMA 2001; 285:2486-2497.
7. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2006; 29 (Suppl 1):s4-s42.
8. Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, et al.; American Heart Association; American Diabetes Association. Primary prevention of cardiovascular diseases in people with diabetes mellitus: A scientific statement from the American Heart Association and the American Diabetes Association. Circulation 2007; 115:114-126. (Pubitemid 46058619)
9. Janne d'Othée B, Siebert U, Cury R, Jadvar H, Dunn EJ, Hoffmann U. A systematic review on diagnostic accuracy of CT-based detection of significant coronary artery disease. Eur J Radiol 2008; 65:449-461.
10. Min JK, Lin FY, Gidseg DS, Weinsaft JW, Berman DS, Shaw LJ, et al. Determinants of coronary calcium conversion among patients with a normal coronary calcium scan: what is the 'warranty period' for remaining normal?. J Am Coll Cardiol 2010; 55:1110-1117.
11. Elkeles RS, Godsland IF, Feher MD, Rubens MB, Roughton M, Nugara F, et al. Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: The PREDICT study. Eur Heart J 2008; 29:2244-2251.
12. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004; 27 (Suppl 1):s5-s10.
13. Bax JJ, Young LH, Frye RL, Bonow RO, Steinberg HO, Barrett EJ; ADA. Screening for coronary artery disease in patients with diabetes. Diabetes Care 2007; 30:2729-2736.
14. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology and management. JAMA 2002; 287:2570-2581.
15. Bordier L, Garcia C, Goasdoué P, Mayaudon H, Dupuy O, Guiraudet O, et al. What is the role of computed tomographic coronary angiography in diabetic patients? Diabetes and Metabolism 2008; 34:26-32.
16. Tsai JC, Chang DM, Chung FM,Wu JC, Shin SJ, Lee YJ. The Association of silent coronary artery disease and metabolic syndrome in chinese with type 2 diabetes mellitus. Rev Diabet Stud 2004; 1:18-28.
17. ACCF/AHA/ACP. 2009 competence and training statement: A curriculum on prevention of cardiovascular disease. J AmCollCardio 2009; 54:1336-1363.
18. De Lorenzo A, Lima RS, Siqueira-Filho AG, Pantoja MR. Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. Am J Cardiol 2002; 90:827-832.
19. Giri S, Shaw LJ, Murthy DR, Travin MI, Miller DD, Hachamovitch R, et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 2002; 105:32-40.
20. Albers AR, Krichavsky MZ, Balady GJ. Stress testing in patients with diabetes mellitus. Diagnostic and prognostic value. Circulation 2006; 113:583-592.
21. Budoff MJ, Gul KM. Expert review on coronary calcium. Vascular Health and Risk Management 2008; 4:315-324.
22. Raggi P. Coronary-calcium screening to improve risk stratification in primary prevention. J La State Med Soc 2002; 154:314-318.
23. Shaw LJ, Raggi P, Schisterman E, Berman DS, Callister TQ. Prognostic value of cardiac risk factors and coronary artery calcium screening for all cause mortality. Radiology 2003; 28:826-833.
24. Wayhs R, Zelinger A, Raggi P. High coronary artery calcium scores pose an extremely elevated risk for hard events. J Am Coll Cardiol 2002; 39:225-230.
25. Stirban AO, Tschoepe D. Cardiovascular complications in diabetes: Targets and interventions. Diabetes Care 2008; 31 (Suppl 2):S215-S221.
26. Gottlieb I, Miller JM, Arbab-Zadeh A, Dewey M, Clouse ME, Sara L, et al. The absence of coronary calcification does not exclude obstructive coronary artery disease or the need for revascularization in patients referred for conventional coronary angiography. J Am Coll Cardiol 2010; 55:627-634.
27. Budoff MJ, McClelland RL, Nasir K, Greenland P, Kronmal RA, Kondos GT, et al. Cardiovascular events with absent or minimal coronary calcification: The Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J 2009; 158:554-561.
28. Scholte AJ, Schuijf JD, Kharagjitsingh AV, Jukema JW, Pundziute G, van der Wall EE, et al. Prevalence of coronary artery disease and plaque morphology assessed by multi-slice computed tomography coronary angiography and calcium scoring in asymptomatic patients with type 2 diabetes. Heart 2008; 94:290-295.
29. Mann JM, Davies MJ. Vulnerable plaque: relation of characteristics to degree of stenosis in human coronary arteries. Circulation 1996; 94:928-931.
30. Ambrose JA, Tannenbaum MA, Alexopoulos D, Hjemdahl-Monsen CE, Leavy J, Weiss M, et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988; 12:56-62.